The largest database of trusted experimental protocols

Gateway recombinational cloning

Manufactured by Thermo Fisher Scientific
Sourced in United States

Gateway recombinational cloning is a molecular biology technique that enables the efficient and directional transfer of DNA sequences between multiple vectors. It facilitates the rapid generation of recombinant DNA constructs without the need for traditional restriction enzyme-based cloning methods.

Automatically generated - may contain errors

9 protocols using gateway recombinational cloning

1

Construction and Validation of ExsA Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Construction of the ExsDM59R variant has been described previously45 (link). The 1–46 residue ExsD peptide (ExsD1-46) used in the experiments was purchased from New England Peptide, Inc. (Garner, MA, USA).
All ExsA variants were constructed with the QuikChange kit (Agilent Technologies, Santa Clara, CA, USA) using complementary primers with the appropriate base substitutions and pDONR201-wtExsA as template. The mutated genes were sequence-verified and recombined into the pDEST-His-MBP expression plasmid using Gateway recombinational cloning (Invitrogen). The list of primers used can be found in the Supplementary Table S1.
+ Open protocol
+ Expand
2

Cloning UBE3A Constructs for Y2H

Check if the same lab product or an alternative is used in the 5 most similar protocols
ORF clones in pDONR223 containing sequences encoding the three catalytically active and inactive forms of UBE3A [28 (link)] were transferred to the Y2H destination vector pQZ212 (DB vector) by Gateway recombinational cloning (Invitrogen) as described in Dreze et al. [37 (link)]. pQZ212 is a modified version of pVV212, a high-copy 2-micron (2µ) vector, engineered to contain the LEU2 and CAN1 selection markers.
Competent yeast cells of the Y8930c strain (MATα leu2-3,112 trp1-901 his3Δ200 ura3-52 gal4Δgal80ΔGAL2::ADE2 GAL1::HIS3@LYS2 GAL7::lacZ@MET2 cyh2R) were transformed with the cloned DB-ORF constructs [37 (link)]. Yeast cells were plated on selective synthetic complete (SC) solid medium lacking leucine (SC-Leu) to select for transformants.
+ Open protocol
+ Expand
3

Purification of ExsD and ExsA proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression and purification of wild-type ExsD (wtExsD) and wild-type ExsA (wtExsA) followed previously published protocols39 (link),45 (link). Both proteins were respectively overexpressed as His6-MBP-ExsD and His6-MBP-ExsA fusions from the pFS-HMBPExsD and pFS-HMBPExsA vectors constructed by Gateway recombinational cloning (Invitrogen, Carlsbad, CA, USA)58 (link).
+ Open protocol
+ Expand
4

Transgenic Zebrafish Generation via Tol2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transgenesis constructs were assembled using Gateway recombinational cloning (Invitrogen) as previously described [72 (link)]. Transgenic zebrafish lines were generated using the Tol2-system as described [34 (link)]. Supplementary Table 1 lists the primers used. All expression constructs were verified for their sequences before use.
+ Open protocol
+ Expand
5

Cloning and Expression of FPN-1.1 in C. elegans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length wildtype (WT) fpn-1.1 with C-terminal FLAG tag was PCR amplified using primers 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTACATGGCTTGGTTATCCGGAAAAG-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTTTCACTTGTCATCGTCGTCCTTGTAGTCTTCAAAAGTTGGCGAATCCAAC-3′ from cDNA library which was converted from total RNAs isolated from N2 worms (see below). The plasmid was created with Gateway recombinational cloning (Invitrogen). The above PCR product was initially recombined with the pDONR221 vector to create the pENTRY clone. Next, the fpn-1.1 pENTRY construct was recombined into pDEST-sur-5 vector25 (link), under the promoter of the acetoacetyl-coenzyme A synthetase (sur-5) gene. This plasmid was then used to create transgenic worms.
+ Open protocol
+ Expand
6

Bacterial Expression of Mutant BRAF and CRAF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (WT) and mutant human BRAF (232–284) and CRAF/RAF-1 (136–188) entry clones were synthesized with an upstream tobacco etch virus (TEV) protease cleavage site (ENLYFQ/G) and optimized for expression in E. coli by ATUM (Newark, CA). Entry clone inserts were transferred by Gateway recombinational cloning (ThermoFisher, Carlsbad, CA) to pDest-566 (Addgene #11517), a T7-based E. coli expression vector encoding an N-terminal His6-MBP (maltose-binding protein) fusion. All CRD proteins were expressed using LB medium supplemented with 300 mM ZnCl2 as outlined for CRAF (52–188) in (Lakshman et al., 2019 (link)). For 2-liter working volume fermentations, 3-liter Bioflo 110 (Eppendorf) were used, and 20-liter Bioflo IV (Eppendorf) were used for 15-liter working volumes. Antifoam 204 (Sigma) was added at 0.075% v/v and 0.017% v/v, respectively, to the 2- and 15-liter fermenters. All proteins were purified essentially as outlined in (Kopra et al., 2020 (link)) for CRAF RBD (52–131). Specifically, 5 mM TCEP was used in all buffers and the protein occasionally eluted overlapping the salt peak during SEC which then required an additional dialysis step (3K MWCO) to the final buffer.
+ Open protocol
+ Expand
7

Recombinant Rhinovirus 3C Protease Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gateway recombinational cloning (Thermo Fisher Scientific) was used to make an untagged rhinovirus 3C protease expression vector for co-lysis experiments. The 3C protease ORF was amplified by PCR from pET/3C using primers PE-2856 and PE-2857 (Table 1). These primers incorporated the attB recombination sites along with an appropriately positioned ribosome-binding site (RBS) in the PCR product. Subsequently, the PCR product was used in a BP reaction with pDONR221 (Thermo Fisher Scientific) to generate the entry clone pSRK2703. The entry clone was recombined in an LR reaction with pDEST42 (Thermo Fisher Scientific) to generate the IPTG-inducible 3C protease expression vector pSRK2706 (Table 2).
+ Open protocol
+ Expand
8

Recombinant Rhinovirus 3C Protease Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gateway recombinational cloning (Thermo Fisher Scientific) was used to make an untagged rhinovirus 3C protease expression vector for co-lysis experiments. The 3C protease ORF was amplified by PCR from pET/3C using primers PE-2856 and PE-2857 (Table 1). These primers incorporated the attB recombination sites along with an appropriately positioned ribosome-binding site (RBS) in the PCR product. Subsequently, the PCR product was used in a BP reaction with pDONR221 (Thermo Fisher Scientific) to generate the entry clone pSRK2703. The entry clone was recombined in an LR reaction with pDEST42 (Thermo Fisher Scientific) to generate the IPTG (isopropyl β-d-1-thiogalactopyranoside)-inducible 3C protease expression vector pSRK2706 (Table 2).
+ Open protocol
+ Expand
9

Recombinant Expression and Purification of BRAF and CRAF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type and mutant human BRAF (232-284) and CRAF/RAF1 (136-188): Entry clones were synthesized with an upstream tobacco etch virus (TEV) protease cleavage site (ENLYFQ/G) and optimized for expression in E. coli by ATUM (Newark, CA). Entry clone inserts were transferred by Gateway recombinational cloning (ThermoFisher, Carlsbad, CA) to pDest-566 (Addgene #11517), a T7-based E. coli expression vector encoding an N-terminal His6-MBP (maltose-binding protein) fusion. All CRD proteins were expressed using LB medium supplemented with 300 mM ZnCl2 as outlined for CRAF (52-188) in (Lakshman et al. 2019) . For 2-liter working volume fermentations, 3-liter Bioflo 110 (Eppendorf) were used, and 20-liter Bioflo IV (Eppendorf) were used for 15-liter working volumes. Antifoam 204 (Sigma) was added at 0.075% v/v and 0.017% v/v, respectively, to the 2-and 15-liter fermenters. All proteins were purified essentially as outlined in (Kopra et al. 2020) for CRAF RBD (52-131). Specifically, 5 mM TCEP was used in all buffers and the protein occasionally eluted overlapping the salt peak during SEC which then required an additional dialysis step (3K MWCO) to the final buffer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!